Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT02128074 | A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia | PHASE2 | COMPLETED | 32 | — | — | Apr 1, 2014 | Nov 1, 2014 | Aug 24, 2018 | 3 | Israel |
| Arm | Type | Description |
|---|---|---|
| KRX-0502 | EXPERIMENTAL | KRX-0502 (ferric citrate) |
| Name | Type | Description |
|---|---|---|
| KRX-0502 | DRUG | 1g tablets of KRX-0502 |
Inclusion Criteria: * Males and non-lactating females with negative serum pregnancy test (for females of child-bearing potential) at Screening * Age ≥ 18 years * Serum ferritin ≤ 300 ng/mL and TSAT ≤ 25% at Screening * Hemoglobin ≥9.0 g/dL and ≤11.5 g/dL at Screening * eGFR \<60 mL/min at Screening...